Pembroke Management LTD Reduces Stock Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Pembroke Management LTD trimmed its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 1.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 309,514 shares of the company’s stock after selling 4,124 shares during the period. Ryan Specialty comprises about 2.7% of Pembroke Management LTD’s holdings, making the stock its 17th biggest position. Pembroke Management LTD’s holdings in Ryan Specialty were worth $20,549,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. GAMMA Investing LLC increased its stake in Ryan Specialty by 96.4% in the 2nd quarter. GAMMA Investing LLC now owns 605 shares of the company’s stock valued at $35,000 after purchasing an additional 297 shares in the last quarter. Crewe Advisors LLC purchased a new stake in Ryan Specialty during the second quarter worth $39,000. Rothschild Investment LLC acquired a new stake in Ryan Specialty in the second quarter valued at $87,000. Signaturefd LLC increased its position in shares of Ryan Specialty by 12.3% in the third quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock valued at $89,000 after buying an additional 148 shares in the last quarter. Finally, RiverPark Advisors LLC raised its stake in shares of Ryan Specialty by 360.6% during the 1st quarter. RiverPark Advisors LLC now owns 2,773 shares of the company’s stock worth $154,000 after buying an additional 2,171 shares during the last quarter. Hedge funds and other institutional investors own 84.82% of the company’s stock.

Ryan Specialty Trading Up 1.3 %

Shares of Ryan Specialty stock opened at $66.71 on Friday. The firm has a market cap of $17.44 billion, a PE ratio of 86.64, a P/E/G ratio of 1.49 and a beta of 0.62. The company has a quick ratio of 1.09, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a fifty-two week low of $41.49 and a fifty-two week high of $73.10. The business’s fifty day moving average is $67.04 and its two-hundred day moving average is $60.49.

Ryan Specialty (NYSE:RYAN) last released its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, hitting the consensus estimate of $0.41. The firm had revenue of $604.69 million for the quarter, compared to the consensus estimate of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The firm’s revenue for the quarter was up 20.5% compared to the same quarter last year. During the same period in the prior year, the business posted $0.32 earnings per share. Analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.81 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th will be issued a $0.11 dividend. The ex-dividend date is Tuesday, November 12th. This represents a $0.44 dividend on an annualized basis and a yield of 0.66%. Ryan Specialty’s payout ratio is 57.14%.

Insider Transactions at Ryan Specialty

In related news, President Timothy William Turner sold 2,000,000 shares of the firm’s stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $62.45, for a total value of $124,900,000.00. Following the transaction, the president now owns 8,095 shares in the company, valued at approximately $505,532.75. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, Director Nicholas Dominic Cortezi sold 1,500 shares of the company’s stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $65.02, for a total value of $97,530.00. Following the completion of the sale, the director now owns 25,123 shares of the company’s stock, valued at $1,633,497.46. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, President Timothy William Turner sold 2,000,000 shares of the firm’s stock in a transaction dated Friday, August 9th. The shares were sold at an average price of $62.45, for a total value of $124,900,000.00. Following the sale, the president now owns 8,095 shares in the company, valued at approximately $505,532.75. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 2,107,136 shares of company stock worth $131,860,032. 11.10% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. Wells Fargo & Company increased their price objective on shares of Ryan Specialty from $63.00 to $70.00 and gave the company an “equal weight” rating in a research note on Thursday, October 10th. Barclays started coverage on shares of Ryan Specialty in a research report on Wednesday, September 4th. They issued an “overweight” rating and a $76.00 price target on the stock. UBS Group lifted their price objective on Ryan Specialty from $67.00 to $76.00 and gave the stock a “buy” rating in a research report on Tuesday, August 13th. BMO Capital Markets upgraded Ryan Specialty from a “market perform” rating to an “outperform” rating and increased their target price for the company from $65.00 to $75.00 in a report on Tuesday, September 24th. Finally, Bank of America raised their price target on Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a research report on Thursday, October 10th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, Ryan Specialty presently has a consensus rating of “Hold” and an average target price of $70.33.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.